Zealand Pharma A/S (CPH:ZEAL)
Denmark · Delayed Price · Currency is DKK 420.10
+8.20 (1.99%)
At close: Jan 30, 2026
Zealand Pharma Market Cap
Zealand Pharma has a market cap or net worth of 29.59 billion as of January 30, 2026. Its market cap has decreased by -39.82% in one year.
Market Cap
29.59B
Enterprise Value
13.83B
Revenue
9.16B
Ranking
n/a
PE Ratio
4.58
Stock Price
420.10
Market Cap Chart
Since November 24, 2010, Zealand Pharma's market cap has increased from 1.41B to 29.59B, an increase of 2,005.02%. That is a compound annual growth rate of 22.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 29.59B | -9.93% |
| Dec 30, 2025 | 32.85B | -35.01% |
| Dec 30, 2024 | 50.55B | 132.03% |
| Dec 29, 2023 | 21.79B | 110.16% |
| Dec 30, 2022 | 10.37B | 65.31% |
| Dec 30, 2021 | 6.27B | -28.46% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.64T |
| Genmab | 124.55B |
| Coloplast | 120.80B |
| Demant | 46.95B |
| ALK-Abelló | 45.92B |
| H. Lundbeck | 40.70B |
| Ambu A/S | 22.62B |
| GN Store Nord | 16.17B |